Turnover intention and emotional exhaustion "at the top": adapting the job demands-resources model to leaders of addiction treatment organizations.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2746447)

Published in J Occup Health Psychol on January 01, 2009

Authors

Hannah K Knudsen1, Lori J Ducharme, Paul M Roman

Author Affiliations

1: Department of Behavioral Science, University of Kentucky, Lexington, KY 40536-0086, USA. hannah.knudsen@uky.edu

Articles cited by this

The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55

Job burnout. Annu Rev Psychol (2001) 14.59

The job demands-resources model of burnout. J Appl Psychol (2001) 5.16

A meta-analytic examination of the correlates of the three dimensions of job burnout. J Appl Psychol (1996) 3.26

Program change and organizational properties. A comparative analysis. AJS (1967) 2.47

Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01

Patterns of organization and management in private and public substance abuse treatment programs. J Subst Abuse Treat (2006) 1.91

Job resources buffer the impact of job demands on burnout. J Occup Health Psychol (2005) 1.84

The relationship of emotional exhaustion to work attitudes, job performance, and organizational citizenship behaviors. J Appl Psychol (2003) 1.76

Differential challenge stressor-hindrance stressor relationships with job attitudes, turnover intentions, turnover, and withdrawal behavior: a meta-analysis. J Appl Psychol (2007) 1.52

Emotional exhaustion as a predictor of job performance and voluntary turnover. J Appl Psychol (1998) 1.40

On cross-sectional questionnaire studies of relationships between psychosocial conditions at work and health--are they reliable? Int Arch Occup Environ Health (2005) 1.40

Turnover intentions of community mental health workers in psychosocial rehabilitation services. Community Ment Health J (1997) 1.06

Trends in burnout and related measures of organizational stress among leaders of Department of Veterans Affairs medical centers. J Healthc Manag (1999) 0.86

Organizational characteristics associated with hospital CEO turnover. J Healthc Manag (2000) 0.80

Articles by these authors

Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. J Subst Abuse Treat (2007) 2.88

Retaining counseling staff at substance abuse treatment centers: effects of management practices. J Subst Abuse Treat (2003) 2.84

Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. J Subst Abuse Treat (2006) 2.73

Modeling the use of innovations in private treatment organizations: the role of absorptive capacity. J Subst Abuse Treat (2004) 2.51

Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat (2005) 2.36

The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters. Drug Alcohol Depend (2006) 2.30

Counselor emotional exhaustion and turnover intention in therapeutic communities. J Subst Abuse Treat (2006) 2.13

Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol (2006) 2.13

Problem drinking patterns among African Americans: the impacts of reports of discrimination, perceptions of prejudice, and "risky" coping strategies. J Health Soc Behav (2003) 1.97

Service delivery in substance abuse treatment: reexamining "comprehensive" care. J Behav Health Serv Res (2007) 1.93

Research participation and turnover intention: An exploratory analysis of substance abuse counselors. J Subst Abuse Treat (2007) 1.92

Patterns of organization and management in private and public substance abuse treatment programs. J Subst Abuse Treat (2006) 1.91

Adoption and implementation of medications in addiction treatment programs. J Addict Med (2011) 1.89

Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2009) 1.66

Clinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse. J Subst Abuse Treat (2008) 1.59

Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. J Addict Dis (2010) 1.55

Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoption. J Subst Abuse Treat (2008) 1.40

Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine. Am J Addict (2007) 1.40

Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers. J Stud Alcohol Drugs (2007) 1.39

The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment. J Health Soc Behav (2007) 1.39

A categorical typology of naltrexone-adopting private substance abuse treatment centers. J Subst Abuse Treat (2007) 1.34

Counselor attitudes toward the use of motivational incentives in addiction treatment. Am J Addict (2010) 1.33

The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation. J Subst Abuse Treat (2010) 1.30

Counselor attitudes toward pharmacotherapies for alcohol dependence. J Stud Alcohol Drugs (2009) 1.30

Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector. J Stud Alcohol Drugs (2010) 1.22

Predicting closure of private substance abuse treatment facilities. J Behav Health Serv Res (2002) 1.21

Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J (2006) 1.20

Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. J Addict Med (2010) 1.15

A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation. J Stud Alcohol Drugs (2011) 1.14

Job stress and poor sleep quality: data from an American sample of full-time workers. Soc Sci Med (2007) 1.10

Diffusion of contingency management and attitudes regarding its effectiveness and acceptability. Subst Abus (2010) 1.03

Evidence-based treatment for opiate-dependent clients: availability, variation, and organizational correlates. Am J Drug Alcohol Abuse (2006) 1.01

Occupational turnover intentions among substance abuse counselors. J Subst Abuse Treat (2010) 1.00

Total quality management and performance in substance abuse treatment centers. Health Serv Res (2010) 1.00

Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations. J Subst Abuse Treat (2012) 0.98

Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. J Subst Abuse Treat (2010) 0.97

Does service diversification enhance organizational survival?: Evidence from the private substance abuse treatment system. J Behav Health Serv Res (2005) 0.96

Rural and urban similarities and differences in private substance abuse treatment centers. J Psychoactive Drugs (2004) 0.96

Racial and ethnic disparities in SSRI availability in substance abuse treatment. Psychiatr Serv (2007) 0.96

Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. J Stud Alcohol Drugs (2013) 0.96

Why are recovering substance abuse counselors paid less? Subst Abus (2007) 0.95

Financial factors and the implementation of medications for treating opioid use disorders. J Addict Med (2012) 0.95

HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend (2010) 0.95

Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages. J Subst Abuse Treat (2011) 0.94

Management systems, patient quality improvement, resource availability, and substance abuse treatment quality. Health Serv Res (2011) 0.94

Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers. Drug Alcohol Depend (2011) 0.94

A changed America? The effects of September 11th on depressive symptoms and alcohol consumption. J Health Soc Behav (2005) 0.94

The availability of psychiatric programs in private substance abuse treatment centers, 1995 to 2001. Psychiatr Serv (2004) 0.93

A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol. Health Justice (2013) 0.92

Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat (2012) 0.91

Predominantly female caseloads: identifying organizational correlates in private substance abuse treatment centers. J Behav Health Serv Res (2004) 0.88

What are the correlates of substance abuse treatment counselor salaries? J Subst Abuse Treat (2005) 0.88

Modified therapeutic communities and adherence to traditional elements. J Psychoactive Drugs (2009) 0.86

Nurse turnover in substance abuse treatment programs affiliated with the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2010) 0.86

Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach. Addict Behav (2011) 0.86

Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations. Sociol Focus (2009) 0.85

Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv (2008) 0.85

The use of art and music therapy in substance abuse treatment programs. J Addict Nurs (2014) 0.83

Dissemination activities: a critical new role for substance abuse treatment organizations. J Behav Health Serv Res (2014) 0.82

Quality of clinical supervision and counselor emotional exhaustion: the potential mediating roles of organizational and occupational commitment. J Subst Abuse Treat (2013) 0.80

The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment. J Subst Abuse Treat (2013) 0.79

Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. J Addict Dis (2007) 0.79

Counselor attitudes toward and use of evidence-based practices in private substance use disorder treatment centers: a comparison of social workers and non-social workers. Health Soc Work (2012) 0.79

Social workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders. Soc Work Health Care (2013) 0.79

Rural substance use treatment centers in the United States: an assessment of treatment quality by location. Am J Drug Alcohol Abuse (2015) 0.77

Assessment and treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict (2011) 0.77

The availability of integrated care in a national sample of therapeutic communities. J Behav Health Serv Res (2012) 0.77

An exploratory study of alternative configurations of governing boards of substance abuse treatment centers. J Subst Abuse Treat (2011) 0.77

Substance abuse treatment for older adults in private centers. Subst Abus (2011) 0.76

Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams. J Health Hum Serv Adm (2014) 0.76

Incentive-Related Human Resource Practices for Substance Use Disorder Counselors: Salaries, Benefits, and Training. Alcohol Treat Q (2011) 0.75

Health Services Research for Drug and Alcohol Treatment and Prevention. J Drug Issues (2009) 0.75